Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Callens

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Plos Neglected Tropical Diseases|January 17, 2024
Fasciola spp. in Southeast Asia: A systematic reviewVinh Hoang Quang, Bruno Levecke, Dung Do Trung, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 19, 2023
Rapid detection of S. pyogenes and S. pneumoniae in pleural fluid for diagnosis of parapneumonic empyemaKelly De Schuyter, Jerina Boelens, Anne-Sophie Messiaen, et al.
Journal of the International AIDS Society|November 15, 2014
The impact of nevirapine- versus protease inhibitor-based regimens on virological markers of HIV-1 persistence during seemingly suppressive ARTMaja Kiselinova, Maria Anna, Eva Malatinkova, et al.
The Journal of Antimicrobial Chemotherapy|September 2, 2015
HIV-1 RNA and HIV-1 DNA persistence during suppressive ART with PI-based or nevirapine-based regimensMaja Kiselinova, Anna Maria Geretti, Eva Malatinkova, et al.
Viruses|September 28, 2024
SARS-CoV-2 Seropositivity in Nursing Home Staff and Residents during the First SARS-CoV-2 Wave in Flanders, BelgiumLiselore De Rop, Hanne Vercruysse, Ulysse Alenus, et al.
BMC Microbiology|January 23, 2021
Combined oropharyngeal/nasal swab is equivalent to nasopharyngeal sampling for SARS-CoV-2 diagnostic PCRTania Desmet, Peter De Paepe, Jerina Boelens, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 8, 2022
Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trialEls Tobback, Sophie Degroote, Sabine Buysse, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 6, 2016
In replyRose J Kosgei, Joseph K Sitienei, Hillary Kipruto, et al.
Acta Clinica Belgica|June 18, 2017
Prevalence of non-infectious comorbidities in the HIV-positive population in Belgium: a multicenter, retrospective studyJessie Gunter, Steven Callens, Stephane De Wit, et al.
Sexual Health|December 1, 2018
High uptake of pre-exposure prophylaxis (PrEP) during early roll-out in Belgium: results from surveillance reportsBea Vuylsteke, Thijs Reyniers, Catherine Lucet, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Plos Neglected Tropical Diseases|January 17, 2024
Fasciola spp. in Southeast Asia: A systematic reviewVinh Hoang Quang, Bruno Levecke, Dung Do Trung, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 19, 2023
Rapid detection of S. pyogenes and S. pneumoniae in pleural fluid for diagnosis of parapneumonic empyemaKelly De Schuyter, Jerina Boelens, Anne-Sophie Messiaen, et al.
Journal of the International AIDS Society|November 15, 2014
The impact of nevirapine- versus protease inhibitor-based regimens on virological markers of HIV-1 persistence during seemingly suppressive ARTMaja Kiselinova, Maria Anna, Eva Malatinkova, et al.
The Journal of Antimicrobial Chemotherapy|September 2, 2015
HIV-1 RNA and HIV-1 DNA persistence during suppressive ART with PI-based or nevirapine-based regimensMaja Kiselinova, Anna Maria Geretti, Eva Malatinkova, et al.
Viruses|September 28, 2024
SARS-CoV-2 Seropositivity in Nursing Home Staff and Residents during the First SARS-CoV-2 Wave in Flanders, BelgiumLiselore De Rop, Hanne Vercruysse, Ulysse Alenus, et al.
BMC Microbiology|January 23, 2021
Combined oropharyngeal/nasal swab is equivalent to nasopharyngeal sampling for SARS-CoV-2 diagnostic PCRTania Desmet, Peter De Paepe, Jerina Boelens, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 8, 2022
Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trialEls Tobback, Sophie Degroote, Sabine Buysse, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 6, 2016
In replyRose J Kosgei, Joseph K Sitienei, Hillary Kipruto, et al.
Acta Clinica Belgica|June 18, 2017
Prevalence of non-infectious comorbidities in the HIV-positive population in Belgium: a multicenter, retrospective studyJessie Gunter, Steven Callens, Stephane De Wit, et al.
Sexual Health|December 1, 2018
High uptake of pre-exposure prophylaxis (PrEP) during early roll-out in Belgium: results from surveillance reportsBea Vuylsteke, Thijs Reyniers, Catherine Lucet, et al.
Pageof 10